Clinical Trial

Relapse Among Diabetic Ketoacidosis Patients Maintained Basal Bolus Insulin Administration in Combination With Continuous Intravenous Insulin Infusion VS Non Maintaining Basal Insulin Patients

Completed
View on ClinicalTrials.gov →
Summary
This study aimed to assess intensive care unit stay and relapse among patients of Diabetic ketoacidosis (type 1 diabetes mellitus) maintained basal bolus insulin and patients non maintaining along with intervenors insulin infusion.
Trial Details
NCT Number NCT07423559
Lead Sponsor Tanta University
Conditions Diabetic Ketoacidosis, Insulin, Intensive Care Unit Stay
Enrollment 100 participants
Start Date 2023-11-30
Primary Completion 2024-12-30 (estimated)
Study Completion 2024-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-20